Think of GLP-1 therapy as a bridge
Here is what the science actually says about olive oil polyphenols, gut hormones, and metabolic health -- and where the evidence stands right now
Nausea - the most common side effect, reported more frequently at higher doses Diarrhoea Vomiting Constipation Abdominal pain or discomfort These side effects were generally mild to moderate in severity and were most common during the dose escalation period (the first 1216 weeks of treatment, when the dose is gradually increased)
Sinai Hospital and the University of Toronto in Toronto, Canada, is being recognized for having made seminal contributions to our understanding of the physiology and pharmacology of glucagon-like peptides (GLPs) and their use for the benefit of patients. His discoveries of GLP-1, GLP-2, and dipeptidyl peptidase-4 (DPP-4) activity have enabled the development of multiple new innovative classes of medications for the treatment of diabetes, obesity, and obesity-associated comorbidities
PLoS One 2010;5(7):e11749